Martha V. Fernandez-Baca
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Martha V. Fernandez-Baca has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro Castellanos-Gonzalez
Infectious Disease Division, Department of Internal Medicine, University of Texas Medical Branch , Galveston, Texas
3 shared publications - Melinda Barbara Tanabe
Division of Infectious Diseases, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA
3 shared publications - Miguel Mauricio Cabada
Division of Infectious Diseases, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA
3 shared publications - Maria L. Morales
Universidad Peruana Cayetano Heredia and University of Texas Medical Branch Collaborative Research Center, Cusco, Peru
2 shared publications - Abigail Hitchcock
Cusco Branch–Alexander von Humboldt Tropical Medicine Institute/Universidad Peruana Cayetano Heredia, Cusco, Peru
1 shared publication - Alonso Bussalleu
Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute Associated to University of Basel, Allschwil, Switzerland
1 shared publication
Latest Publications
- 2 September 2026
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 115 (3) , 563-570
Frequency, Geospatial Distribution, and Subspecies of Echinococcus granulosus Identified in Dog Stool in Urban Public Spaces of an Endemic Area in Cusco, Peru
: The impact of environmental contamination with Echinococcus granulosus eggs on the transmission to humans remains unknown. The control of free-roaming and stray dogs is a public health problem in urban and periurban areas of the Cusco region, such as the city of Sicuani in the Canchis province. Nearly one in four human cystic echinococcosis cases referred to tertiary hospitals in the Cusco region of Peru is referred from the Sicuani district. This study sought to determine the frequency and spatial distribution of E. granulosus DNA in dog stool collected within urban public spaces of Sicuani. We conducted a cross-sectional study using a systematic 100 × 100-meters 2 grid-based sampling design. Dog stools located at the closest point to georeferenced square vertices were selected for collection. Epidemiologically relevant locations, such as abattoirs and food markets, were also georeferenced. Nineteen (5.5%) of 347 collected samples tested positive for E. granulosus DNA. Polymerase chain reaction (PCR)-positive stools were located at a shorter median distance than negative stools to abattoirs (564 versus 1,292 meters, respectively, P E. granulosus sensu stricto (G1) with close phylogenetic relationship. Our field study revealed that E. granulosus PCR-positive dog stools were associated with spatial proximity to abattoirs. Interventions to decrease E. granulosus infections among dogs, particularly around abattoirs, may decrease the potential environmental contamination with infective stages.
- 2 September 2026
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 115 (3) , 563-570
Frequency, Geospatial Distribution, and Subspecies of Echinococcus granulosus Identified in Dog Stool in Urban Public Spaces of an Endemic Area in Cusco, Peru
: The impact of environmental contamination with Echinococcus granulosus eggs on the transmission to humans remains unknown. The control of free-roaming and stray dogs is a public health problem in urban and periurban areas of the Cusco region, such as the city of Sicuani in the Canchis province. Nearly one in four human cystic echinococcosis cases referred to tertiary hospitals in the Cusco region of Peru is referred from the Sicuani district. This study sought to determine the frequency and spatial distribution of E. granulosus DNA in dog stool collected within urban public spaces of Sicuani. We conducted a cross-sectional study using a systematic 100 × 100-meters 2 grid-based sampling design. Dog stools located at the closest point to georeferenced square vertices were selected for collection. Epidemiologically relevant locations, such as abattoirs and food markets, were also georeferenced. Nineteen (5.5%) of 347 collected samples tested positive for E. granulosus DNA. Polymerase chain reaction (PCR)-positive stools were located at a shorter median distance than negative stools to abattoirs (564 versus 1,292 meters, respectively, P E. granulosus sensu stricto (G1) with close phylogenetic relationship. Our field study revealed that E. granulosus PCR-positive dog stools were associated with spatial proximity to abattoirs. Interventions to decrease E. granulosus infections among dogs, particularly around abattoirs, may decrease the potential environmental contamination with infective stages.
- Open Access
The Recombinase Polymerase Amplification Test for Strongyloides stercoralis Is More Sensitive than Microscopy and Real-Time PCR in High-Risk Communities of Cusco, Peru
Strongyloidiasis is a neglected, soil-transmitted helminth infection prevalent worldwide. The true burden of strongyloidiasis is unclear due to the lack of sensitive, field-friendly diagnostic tests. PCR tests to detect Strongyloides DNA in stool are sensitive and specific, but the need for expensive equipment limits their use in endemic regions. Isothermal PCR amplification tests are easier to deploy while maintaining sensitivity and specificity. We developed and evaluated a recombinase polymerase amplification lateral flow assay (RPA-LFA) to detect Strongyloides stercoralis in human stool samples. Three hundred stool samples were collected in three communities in the jungle of Cusco, Peru. Samples were tested for S. stercoralis larvae using microscopy (Baermann’s, agar plate culture (APC), and rapid sedimentation), real-time PCR, and RPA-LF for Strongyloides DNA. The RPA-LFA showed an analytical limit of detection of 20 pg/µL. The prevalence of S. stercoralis was 27%, 38%, 46.3%, and 46% using microscopy, PCR, microscopy/PCR, and RPA-LFA, respectively. RPA-LFA had a sensitivity and specificity of 59.3% and 58.9%, 66.2% and 71.4%, and 77.2% and 73.1% when microscopy, microscopy/PCR, and real-time PCR were used as the gold standards, respectively. The Strongyloides RPA-LFA is a novel, fast, highly sensitive, and specific molecular method with the potential for deployment in endemic regions.
Open AccessThe Recombinase Polymerase Amplification Test for Strongyloides stercoralis Is More Sensitive than Microscopy and Real-Time PCR in High-Risk Communities of Cusco, Peru
Strongyloidiasis is a neglected, soil-transmitted helminth infection prevalent worldwide. The true burden of strongyloidiasis is unclear due to the lack of sensitive, field-friendly diagnostic tests. PCR tests to detect Strongyloides DNA in stool are sensitive and specific, but the need for expensive equipment limits their use in endemic regions. Isothermal PCR amplification tests are easier to deploy while maintaining sensitivity and specificity. We developed and evaluated a recombinase polymerase amplification lateral flow assay (RPA-LFA) to detect Strongyloides stercoralis in human stool samples. Three hundred stool samples were collected in three communities in the jungle of Cusco, Peru. Samples were tested for S. stercoralis larvae using microscopy (Baermann’s, agar plate culture (APC), and rapid sedimentation), real-time PCR, and RPA-LF for Strongyloides DNA. The RPA-LFA showed an analytical limit of detection of 20 pg/µL. The prevalence of S. stercoralis was 27%, 38%, 46.3%, and 46% using microscopy, PCR, microscopy/PCR, and RPA-LFA, respectively. RPA-LFA had a sensitivity and specificity of 59.3% and 58.9%, 66.2% and 71.4%, and 77.2% and 73.1% when microscopy, microscopy/PCR, and real-time PCR were used as the gold standards, respectively. The Strongyloides RPA-LFA is a novel, fast, highly sensitive, and specific molecular method with the potential for deployment in endemic regions.
- Open Access
A PCR Test Using the Mini-PCR Platform and Simplified Product Detection Methods Is Highly Sensitive and Specific to Detect Fasciola hepatica DNA Mixed in Human Stool, Snail Tissue, and Water DNA Specimens
Fasciola hepatica has a complex lifecycle with multiple intermediate and definitive hosts and influenced by environmental factors. The disease causes significant morbidity in children and its prevalent worldwide. There is lack of data about distribution and burden of the disease in endemic regions, owing to poor efficacy of the different diagnostic methods used. A novel PCR-based test was developed by using a portable mini-PCR® platform to detect Fasciola sp. DNA and interpret the results via a fluorescence viewer and smartphone image analyzer application. Human stool, snail tissue, and water samples were used to extract DNA. Primers targeting the ITS-1 of the 18S rDNA gene of Fasciola sp. were used. The limit of detection of the mini-PCR test was 1 fg/μL for DNA samples diluted in water, 10 fg/μL for Fasciola/snail DNA scramble, and 100 fg/μL for Fasciola/stool DNA scramble. The product detection by agarose gel, direct visualization, and image analyses showed the same sensitivity. The Fh mini-PCR had a sensitivity and specificity equivalent to real-time PCR using the same specimens. Testing was also done on infected human stool and snail tissue successfully. These experiments demonstrated that Fh mini-PCR is as sensitive and specific as real time PCR but without the use of expensive equipment and laboratory facilities. Further testing of multiple specimens with natural infection will provide evidence for feasibility of deployment to resource constrained laboratories.
Open AccessA PCR Test Using the Mini-PCR Platform and Simplified Product Detection Methods Is Highly Sensitive and Specific to Detect Fasciola hepatica DNA Mixed in Human Stool, Snail Tissue, and Water DNA Specimens
Fasciola hepatica has a complex lifecycle with multiple intermediate and definitive hosts and influenced by environmental factors. The disease causes significant morbidity in children and its prevalent worldwide. There is lack of data about distribution and burden of the disease in endemic regions, owing to poor efficacy of the different diagnostic methods used. A novel PCR-based test was developed by using a portable mini-PCR® platform to detect Fasciola sp. DNA and interpret the results via a fluorescence viewer and smartphone image analyzer application. Human stool, snail tissue, and water samples were used to extract DNA. Primers targeting the ITS-1 of the 18S rDNA gene of Fasciola sp. were used. The limit of detection of the mini-PCR test was 1 fg/μL for DNA samples diluted in water, 10 fg/μL for Fasciola/snail DNA scramble, and 100 fg/μL for Fasciola/stool DNA scramble. The product detection by agarose gel, direct visualization, and image analyses showed the same sensitivity. The Fh mini-PCR had a sensitivity and specificity equivalent to real-time PCR using the same specimens. Testing was also done on infected human stool and snail tissue successfully. These experiments demonstrated that Fh mini-PCR is as sensitive and specific as real time PCR but without the use of expensive equipment and laboratory facilities. Further testing of multiple specimens with natural infection will provide evidence for feasibility of deployment to resource constrained laboratories.
- Open Access
- 1 May 2020
- Published by Universidad Tecnologica Indoamerica in CienciAmérica
- Vol. 9 (2) , 207-226
Bioseguridad en laboratorios de diagnóstico molecular de SARS-CoV-2 (COVID-19) mediante RT-qPCR
La pandemia del síndrome respiratorio agudo conocido como COVID-19 y causada por el virus SARS-CoV-2, ha obligado a diversos laboratorios alrededor del mundo a rediseñar y reforzar sus programas de bioseguridad con la finalidad de facilitar el diagnóstico de la enfermedad y colaborar con datos epidemiológicos para la toma de decisiones asociadas a mitigación y control. Una combinación de buenas prácticas de laboratorio y procedimientos claramente definidos, apoyados en la adecuación de la infraestructura, son necesarios para proteger al personal de laboratorio y asegurar la reproducibilidad de los resultados generados. En esta revisión se muestran los lineamientos de bioseguridad fundamentales a implementar en los laboratorios de diagnóstico de la COVID-19, basados en RT-qPCR. El establecimiento del nivel de seguridad biológica a adoptar, así como de los procedimientos operativos estándar, dependerán de la evaluación de riesgo derivada de las actividades intrínsecas del laboratorio. Hasta la fecha, la OMS ha recomendado un nivel 2 de seguridad biológica NBS-2 (BSL-2), con medidas intensificadas de nivel 3 NBS-3 (BSL-3), para actividades de diagnóstico, con prácticas y equipos de protección personal que minimicen la generación de aerosoles y reduzcan la probabilidad de infecciones adquiridas en laboratorio. De igual forma, se ha hecho énfasis en un flujo de trabajo que tome en cuenta el transporte de la muestra bajo reglamentos internacionales y procedimientos para la inactivación del virus, compatibles con la prueba diagnóstica o con los protocolos para la descontaminación de superficies. A pesar del reto que conlleva la adecuación de programas de mitigación ante un patógeno relativamente desconocido como el SARS-CoV-2, es importante destacar que la cultura de bioseguridad permite reducir los riesgos del personal y del medio ambiente y asegurar la calidad de los resultados generados, que permitan contribuir significativamente a lograr el control de la enfermedad.
- 1 May 2020
- Published by Universidad Tecnologica Indoamerica in CienciAmérica
- Vol. 9 (2) , 207-226
Open AccessBioseguridad en laboratorios de diagnóstico molecular de SARS-CoV-2 (COVID-19) mediante RT-qPCR
La pandemia del síndrome respiratorio agudo conocido como COVID-19 y causada por el virus SARS-CoV-2, ha obligado a diversos laboratorios alrededor del mundo a rediseñar y reforzar sus programas de bioseguridad con la finalidad de facilitar el diagnóstico de la enfermedad y colaborar con datos epidemiológicos para la toma de decisiones asociadas a mitigación y control. Una combinación de buenas prácticas de laboratorio y procedimientos claramente definidos, apoyados en la adecuación de la infraestructura, son necesarios para proteger al personal de laboratorio y asegurar la reproducibilidad de los resultados generados. En esta revisión se muestran los lineamientos de bioseguridad fundamentales a implementar en los laboratorios de diagnóstico de la COVID-19, basados en RT-qPCR. El establecimiento del nivel de seguridad biológica a adoptar, así como de los procedimientos operativos estándar, dependerán de la evaluación de riesgo derivada de las actividades intrínsecas del laboratorio. Hasta la fecha, la OMS ha recomendado un nivel 2 de seguridad biológica NBS-2 (BSL-2), con medidas intensificadas de nivel 3 NBS-3 (BSL-3), para actividades de diagnóstico, con prácticas y equipos de protección personal que minimicen la generación de aerosoles y reduzcan la probabilidad de infecciones adquiridas en laboratorio. De igual forma, se ha hecho énfasis en un flujo de trabajo que tome en cuenta el transporte de la muestra bajo reglamentos internacionales y procedimientos para la inactivación del virus, compatibles con la prueba diagnóstica o con los protocolos para la descontaminación de superficies. A pesar del reto que conlleva la adecuación de programas de mitigación ante un patógeno relativamente desconocido como el SARS-CoV-2, es importante destacar que la cultura de bioseguridad permite reducir los riesgos del personal y del medio ambiente y asegurar la calidad de los resultados generados, que permitan contribuir significativamente a lograr el control de la enfermedad.